U.S. federal trademark · Serial No. 85437192
Medical diagnostic testing and treatment services for humans with metabolic disorders such as diabetes, Alzheimer's, Parkinson's disease and diseases of reduced cellular energy all of which respond by normalization of metabolic integrity
Educational services, namely, providing training to medical personnel and the general public about metabolic deficiencies which allows them to achieve normalized cellular energy (ATP)
Software for processing medical data, namely, diagnosis and treatment of abnormal blood glucose to provide real time review of patient outcomes and remotely view the level of care and other medical information which is helpful in protocol verification and refinements of a treatment to normalize metabolism
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.